Incidence rates and treatment of neuropathic pain conditions in the general population

Pain

Volumn 137, Issue 3, 2008, Pages 681-688

  Dieleman, Jeanne P ^a   Kerklaan, Joost ^a   Huygen, Frank J P M ^a   Bouma, Paul A D ^b   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Ziekenhuis Hilversum   (Netherlands)

Author keywords

Epidemiology; Incidence rate; Neuralgia; Neuropathic pain; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; HYPNOTIC SEDATIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONONEUROPATHY; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 47049115005     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.03.002     Document Type: Article

References (31)

1. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
2. Balderischi M., Inzitari M., Di Carlo A., Farchi G., Scafato E., Inzitari D., and ILSA Working Group. Epidemiology of distal symmetrical neuropathies in the Italian elderly. Neurology 68 (2007) 1460-1467
3. Bennett M.I., Smith B.H., Torrance N., and Lee A.J. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122 (2006) 289-294
4. Bennett M.I., Smith B.H., Torrance N., and Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6 (2005) 149-158
5. Berger A., Dukes E.M., and Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5 (2004) 143-149
6. Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., et al. Development and validation of the neuropathic pain symptom inventory. Pain 108 (2004) 248-257
7. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2007 [Sep 19. Epub ahead of print].
8. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 47 (1991) 644-666
9. Cocito D., Paolasso I., Pazzaglia C., Tavella A., Poglio F., Ciaramitaro P., et al. Pain affects the quality of life of neuropathic patients. Neurol Sci 27 (2006) 155-160
10. Collins S.D., and Chessell I.P. Emerging therapies for neuropathic pain. Expert Opin Emerg Drugs 10 (2005) 95-108
11. Colombo B., Annovazzi P.O., and Comi G. Medications for neuropathic pain: current trends. Neurol Sci 27 Suppl. 2 (2006) S183-S189
12. Crooks R.J., Jones D.A., and Fiddian A.P. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis 80 Suppl. (1991) 62-68
13. Dworkin R.H. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 18 (2002) 343-349
14. Fox C.S., Pencina M.J., Meigs J.B., Vasan R.S., Levitzky Y.S., and D'Agostino Sr. R.B. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham heart study. Circulation 113 (2006) 2914-2918
15. Galvez R., Marsal C., Vidal J., Ruiz M., and Rejas J. Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Eur J Pain 11 (2006) 244-255
16. Hall G.C., Carroll D., Parry D., and McQuay H.J. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122 (2006) 156-162
17. Jackson J.L., Gibbons R., Meyer G., and Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med 157 (1997) 909-912
18. Latinovic R., Gulliford M.C., and Hughes R.A. Incidence of common compressive neuropathies in primary care. J Neurol Neurosurg Psychiatry 77 (2006) 263-265
19. MacDonald B.K., Cockerell O.C., Sander J.W., and Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123 (2000) 665-676
20. Marchettini P. The burning case of neuropathic pain wording. Pain 114 (2005) 313-314
21. Martyn C.N., and Hughes R.A. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62 (1997) 310-318
22. McDermott A.M., Toelle T.R., Rowbotham D.J., Schaefer C.P., and Dukes E.M. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 10 (2006) 127-135
23. Mondelli M., Giannini F., and Giacchi M. Carpal tunnel syndrome incidence in a general population. Neurology 58 (2002) 289-294
24. Nordstrom D.L., DeStefano F., Vierkant R.A., and Layde P.M. Incidence of diagnosed carpal tunnel syndrome in a general population. Epidemiology 9 (1998) 342-345
25. Rossignol M., Stock S., Patry L., and Armstrong B. Carpal tunnel syndrome: what is attributable to work? The Montreal study. Occup Environ Med 54 (1997) 519-523
26. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005 [CD005454].
27. Stevens J.C., Sun S., Beard C.M., O'Fallon W.M., and Kurland L.T. Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology 38 (1988) 134-138
28. Torrance N., Smith B.H., Bennett M.I., and Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 (2006) 281-289
29. Vlug A.E., van der Lei J., Mosseveld B.M., van Wijk M.A., van der Linden P.D., Sturkenboom M.C., et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 38 (1999) 339-344
30. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005a [CD005452].
31. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 2005b [CD005451].